Collagen Crosslinking for Keratoconus: Cellular Signaling Mechanisms

Collagen crosslinking (CXL) is a widely used treatment to halt the progression of keratoconus (KC). Unfortunately, a significant number of patients with progressive KC will not qualify for CXL, including those with corneas thinner than 400 µm. The present study aimed to investigate the molecular eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamichos, Dimitrios, Nicholas, Sarah E., Khan, Asher, Riaz, Kamran M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135890/
https://www.ncbi.nlm.nih.gov/pubmed/37189443
http://dx.doi.org/10.3390/biom13040696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135890/
https://www.ncbi.nlm.nih.gov/pubmed/37189443
http://dx.doi.org/10.3390/biom13040696

Ejemplares similares